An official website of the United States government
Home
Name
Leukine
Alternate Names
CSF39300
Granulocyte macrophage colony-stimulating factor
Prokine
rGM-CSF
rhu GM-CSF
Sargramostim
GM-CSF
Abbreviations
None
Category
Ancillary Agent
Subcategory
None
NSC Number
617589
643496
613795
Primary Site
other cancer
Skin
Histology
None
Remarks
On March 29, 2018: The FDA approved use of Leukine (sargramostim) to increase survival in adult and pediatric patients acutely exposed to myelosuppressive doses of radiation (Hematopoietic Syndrome of Acute Radiation Syndrome, or H-ARS). Leukine can help patients with H-ARS by facilitating recovery of bone marrow cells that develop into white blood cells that help fight off infections.
Coding
This drug should NOT be coded
